Yi-Hsiang Huang Selected Research

Serum Albumin

12/2018	Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy.
3/2016	Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems.
10/2015	Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
12/2014	A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.
9/2014	Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact.
1/2012	Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
2/2010	Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
5/2005	Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
4/2005	Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
10/2004	The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Hsiang Huang Research Topics

Disease

99	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 03/2002
73	Neoplasms (Cancer) 07/2022 - 10/2004
54	Fibrosis (Cirrhosis) 10/2022 - 07/2006
24	Chronic Hepatitis C 01/2022 - 03/2014
24	Liver Neoplasms (Liver Cancer) 01/2022 - 05/2005
21	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 07/2006
19	Infections 08/2022 - 05/2007
19	Ascites 01/2022 - 03/2004
17	Chronic Hepatitis B 04/2022 - 05/2009
16	Hepatitis B 07/2022 - 06/2007
14	Inflammation (Inflammations) 12/2021 - 10/2011
14	End Stage Liver Disease 11/2020 - 12/2004
13	Liver Diseases (Liver Disease) 10/2021 - 11/2002
11	Hepatitis 04/2021 - 11/2002
10	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2009
10	Portal Hypertension 12/2021 - 03/2015
9	Disease Progression 04/2022 - 12/2004
7	Hepatitis C 01/2021 - 03/2014
7	Fatty Liver 01/2019 - 01/2013
6	Chronic Renal Insufficiency 01/2022 - 03/2004
6	Hepatic Encephalopathy 01/2020 - 07/2011
5	Liver Failure 08/2021 - 07/2011
5	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2016
4	Virus Diseases (Viral Diseases) 02/2022 - 05/2009
4	Sepsis (Septicemia) 01/2022 - 01/2020
4	Rheumatoid Arthritis 11/2021 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2010
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 03/2015
4	Renal Insufficiency (Renal Failure) 04/2020 - 02/2010
4	Chronic Hepatitis D 04/2009 - 03/2005
3	Carcinogenesis 04/2022 - 05/2009
3	Hemorrhage 07/2020 - 09/2010
3	Fatigue 03/2019 - 01/2017
3	Insulin Resistance 01/2019 - 01/2016
3	Body Weight (Weight, Body) 01/2019 - 10/2011

Drug/Important Bio-Agent (IBA)

32	BilirubinIBA 07/2022 - 02/2010
32	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2010
28	AlbuminsIBA 07/2022 - 12/2011
22	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2007
21	Fetal Proteins (Fetoprotein)IBA 07/2022 - 05/2011
20	InterferonsIBA 01/2022 - 03/2014
17	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 02/2004
13	Cytidine Triphosphate (CTP)IBA 11/2021 - 12/2004
12	Alanine Transaminase (SGPT)IBA 12/2021 - 04/2005
11	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 03/2015
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
11	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2008
10	Hepatitis B e AntigensIBA 09/2021 - 03/2010
10	Serum AlbuminIBA 12/2018 - 10/2004
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2015 - 10/2009
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
8	Pharmaceutical PreparationsIBA 11/2021 - 07/2007
8	Ribavirin (Virazole)FDA LinkGeneric 10/2021 - 01/2017
8	CytokinesIBA 04/2021 - 11/2014
8	CreatinineIBA 02/2021 - 03/2004
7	SofosbuvirIBA 02/2022 - 12/2018
7	Rituximab (Mabthera)FDA Link 11/2021 - 03/2010
6	Alkaline PhosphataseIBA 12/2021 - 01/2016
6	entecavir FDA Link 12/2018 - 03/2010
6	SodiumIBA 09/2014 - 09/2009
5	NivolumabIBA 01/2022 - 01/2020
5	daclatasvirIBA 01/2021 - 12/2018
5	AntigensIBA 10/2020 - 06/2010
4	regorafenibIBA 04/2022 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 02/2020
4	Thioacetamide (Thioacetamid)IBA 01/2021 - 11/2014
4	Proton Pump InhibitorsIBA 12/2020 - 01/2017
4	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2008
4	Surface Antigens (Surface Antigen)IBA 01/2020 - 08/2015
3	LipidsIBA 01/2022 - 01/2017
3	Sirtuin 1IBA 12/2021 - 01/2019
3	salicylhydroxamic acid (SHAM)IBA 12/2021 - 04/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 12/2016
3	peginterferon alfa-2a (Pegasys)FDA Link 09/2021 - 01/2013
3	EnzymesIBA 01/2021 - 07/2007
3	Choline (Choline Chloride)IBA 01/2021 - 01/2013
3	Methionine (L-Methionine)FDA Link 01/2021 - 01/2013
3	Transaminases (Aminotransferases)IBA 01/2021 - 01/2008
3	asunaprevirIBA 01/2021 - 12/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
3	dasabuvirIBA 12/2020 - 12/2018
3	ombitasvirIBA 12/2020 - 12/2018
3	paritaprevirIBA 12/2020 - 12/2018
3	Ritonavir (Norvir)FDA Link 12/2020 - 12/2018
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2017
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 04/2018 - 01/2015
3	aliskiren FDA Link 01/2016 - 12/2012

Therapy/Procedure

68	Therapeutics 11/2022 - 11/2002
18	Radiofrequency Ablation 10/2020 - 01/2008
12	Surgical Instruments (Clip) 04/2021 - 10/2004
11	Drug Therapy (Chemotherapy) 02/2022 - 05/2009
8	Immunotherapy 01/2022 - 01/2020
6	Ligation 12/2021 - 11/2014
6	Liver Transplantation 01/2019 - 12/2004
5	Transplantation 12/2021 - 01/2012
4	Stents 01/2022 - 10/2019
3	Contraindications 01/2022 - 01/2017
3	Organ Transplantation 07/2020 - 01/2019